Full View

Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis

A Jacobi, SJ Rustenbach… - International journal of …, 2016 - Wiley Online Library
Background Psoriasis often requires lifelong therapy, and adherence to treatment is
considered a marker for treatment success. Data on the drug survival of biologics in …
被引用次数：57 相关文章

Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis.

A Jacobi, SJ Rustenbach, M Augustin - International Journal of …, 2015 - europepmc.org
Background Psoriasis often requires lifelong therapy, and adherence to treatment is
considered a marker for treatment success. Data on the drug survival of biologics in …

Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis

A Jacobi, SJ Rustenbach… - International journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Psoriasis often requires lifelong therapy, and adherence to treatment is
considered a marker for treatment success. Data on the drug survival of biologics in …

[引用][C] Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis

A Jacobi, SJ Rustenbach, M Augustin - International Journal of …, 2015 - cir.nii.ac.jp
Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis

A Jacobi, SJ Rustenbach, M Augustin - International Journal of …, 2016 - infona.pl
Background Psoriasis often requires lifelong therapy, and adherence to treatment is
considered a marker for treatment success. Data on the drug survival of biologics in …